Cohance Lifesciences Limited
COHANCE
Rank in Stocks
#6379
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Share Price
$5.05
Last synced: 2026-10-19
Market Cap
$1.93B
Change (1 day)
-1.44%
Change (1 year)
-57.38%
Country
IN
Trade Cohance Lifesciences Limited (COHANCE)
Category
Healthcare
Earnings for Cohance Lifesciences Limited (COHANCE)
Earnings in Jun 2025 TTM: $37.76M
According to Cohance Lifesciences Limited latest financial reports the company's current earnings are $37.76M. In 2024 the company made an earning of $48.65M, a decrease compared to its 2023 earnings that were of $68.11M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Cohance Lifesciences Limited from 2019 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $37.76M | -6.11% |
| 2025 | $40.21M | -17.35% |
| 2024 | $48.65M | -28.57% |
| 2023 | $68.11M | -22.55% |
| 2022 | $87.95M | 37.66% |
| 2021 | $63.89M | 18.98% |
| 2020 | $53.70M | 136.19% |
| 2019 | $22.73M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 4,573.48% |
IN
|
